Sabrina O.
- Country
- Germany
- Department
- Medicine III, Hematology and Oncology
Research Overview
- Phase 3 Study of Adjuvant Daraxonrasib Versus Observation in Patients With Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant or Adjuvant Chemotherapy
- Phase 3 Randomized Double-Blind Study of INCA33890 Plus First-Line Chemotherapy and Bevacizumab in Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3 Randomized Trial of Daraxonrasib Monotherapy or Daraxonrasib + Gemcitabine/Nab‑Paclitaxel vs Gemcitabine/Nab‑Paclitaxel in First‑Line Metastatic Pancreatic Cancer
Data & Insights
Has run more than one trial at 101 of 225 partner sites.
Specializations
Colorectal Cancer Research
The investigator specializes in treating patients with KRAS/NRAS and BRAF wild-type colorectal cancer, with particular emphasis on unresectable and metastatic cases. Their research encompasses both treatment-naïve patients and those with recurrent disease.
- Left-sided colorectal cancer management
- Targeted therapy approaches
- Advanced-stage treatment strategies
The investigator focuses on evaluating novel therapeutic combinations and comparing treatment efficacy in different patient populations.
Pancreatic Cancer Studies
The investigator conducts research in metastatic pancreatic ductal adenocarcinoma (PDAC), with specific attention to previously treated patients. Their work includes evaluation of innovative therapeutic approaches for this challenging condition.
- Advanced PDAC treatment
- RAS G12 population studies
- Standard therapy comparison research
The research focuses on developing more effective treatment strategies for patients with metastatic pancreatic cancer.
Treatment Outcomes
The investigator's research emphasizes measuring crucial clinical outcomes in gastrointestinal oncology. Their work involves comprehensive evaluation of treatment effectiveness through key survival metrics.
- Progression-free survival assessment
- Overall survival analysis
- Comparative treatment efficacy
The research involves evaluation of both established and emerging therapeutic combinations in gastrointestinal cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.